Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has announced the cessation of several securities due to unmet conditions, affecting options and share rights totaling approximately 899,742 units. The specific securities affected include options expiring in January and November 2023 and share rights and appreciation rights that have lapsed as of early 2024.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
